Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 30, 2025International Journal of Advanced Research in Science Communication and TechnologyOpen Access

Design and Development of Optimised Nanostructured Polymeric Systems of Raloxifene For Improved Biopharmaceutical Application in Breast Cancer: A Review

View Full Paper
Ask AI
Bookmark
Share

Authors

KSKanwaldeep SinghRSRam Babu SharmaSSakshi

Discussion

Loading...

Member takes

Overview

This review demonstrates enhanced drug delivery and bioavailability for raloxifene in breast cancer, suggesting nanotechnology may improve therapeutic outcomes.

Key Points

  • Breast cancer is the most common malignancy in women, with over 2 million diagnoses in 2018.
  • Nanostructured polymeric systems improve the solubility and bioavailability of raloxifene significantly.
  • Current challenges in clinical application include complex manufacturing and regulatory hurdles for nanocarrier systems.
  • Future efforts must focus on scalable production techniques and robust toxicological assessments to ensure safety and efficacy.

Cite This Study

Singh et al. (2025) studied this question.

synapsesocial.com/papers/689a094be6551bb0af8cf130https://doi.org/10.48175/ijarsct-28523
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanotechnology-Driven Therapeutic Potential of Raloxifene in Osteoporosis and Cancer: A Recent Review2025
  2. 2Raloxifene-Loaded Lipid Nanovesicles: A Journey to Select the Optimal Nanocarrier Formulation Through Characterization and Cytotoxic Analysis2025
  3. 3Codelivery of Raloxifene and Rutin as PEGylated Nanoliposomes: Formulation, Characterization, and Prophylactic Activity Against Breast Cancer2025
  4. 4Targeted Delivery of Raloxifene via RGD-functionalized Chitosan Nanoparticle Selectively Attenuates Breast Tumor Growth2025
  5. 5Current Insights into Polymeric Nanocarriers for Delivery of Phytomedicines in Breast Cancer Therapy2025